跳至主要内容
临床试验/CTRI/2023/03/050788
CTRI/2023/03/050788尚未招募2 期

To evaluate the safety and efficacy of a Topical Unani formulation in the management of NÄ?r-fÄ?rsÄ« (Eczema) with standard control.

Central Council for Research in Unani Medicine,New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Clinically diagnosed patients of eczema.
  • Mild to moderate case of eczema.
  • Patients who have agreed to sign the informed consent, follow the protocol and willing to participate the clinical trial voluntarily.

排除标准

  • Patients below 18 and above 30 years are excluded.
  • Local wound and infection.
  • Patients with systemic diseases like cardiovascular, renal and hepatic dysfunctions.
  • Severe case of Dermatitis.
  • Pregnancy and Lactation.

研究者

发起方
Central Council for Research in Unani Medicine,New Delhi

相似试验

To assess the effectiveness of a local Unani... | 临床试验